Literature DB >> 30159667

Improving outcomes with pharmacotherapy to treat acute esophageal variceal bleeding.

C E Eapen1, Subramani Kandasamy2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30159667     DOI： 10.1007/s12664-018-0887-0

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  9 in total

Review 1.  Measurement of portal pressure.

Authors:  Juan G Abraldes; Philippe Sarlieve; Puneeta Tandon
Journal:  Clin Liver Dis       Date:  2014-08-21       Impact factor: 6.126

Review 2.  Short article: Noninvasive assessment of portal hypertension and detection of esophageal varices in cirrhosis: state-of-the-art.

Authors:  Ana C de Oliveira
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-05       Impact factor: 2.566

3.  Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison.

Authors:  Chao Ding; Xingjiang Wu; Xinxin Fan; Changsheng He; Jieshou Li
Journal:  J Gastroenterol Hepatol       Date:  2013-07       Impact factor: 4.029

4.  Comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial.

Authors:  Sanjeev Kumar Jha; Manish Mishra; Ashish Jha; Vishwa Mohan Dayal
Journal:  Indian J Gastroenterol       Date:  2018-08-21

Review 5.  Terlipressin: Current and emerging indications in chronic liver disease.

Authors:  Timothy Papaluca; Paul Gow
Journal:  J Gastroenterol Hepatol       Date:  2018-03       Impact factor: 4.029

Review 6.  Nonendoscopic management strategies for acute esophagogastric variceal bleeding.

Authors:  Sanjaya K Satapathy; Arun J Sanyal
Journal:  Gastroenterol Clin North Am       Date:  2014-09-27       Impact factor: 3.806

7.  Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.

Authors:  S Møller; E F Hansen; U Becker; K Brinch; J H Henriksen; F Bendtsen
Journal:  Liver       Date:  2000-02

8.  Time profile of the haemodynamic effects of terlipressin in portal hypertension.

Authors:  A Escorsell; J C Bandi; E Moitinho; F Feu; J C García-Pagan; J Bosch; J Rodés
Journal:  J Hepatol       Date:  1997-03       Impact factor: 25.083

9.  Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.

Authors:  Marta Cavallin; Salvatore Piano; Antonietta Romano; Silvano Fasolato; Anna Chiara Frigo; Gianpiero Benetti; Elisabetta Gola; Filippo Morando; Marialuisa Stanco; Silvia Rosi; Antonietta Sticca; Umberto Cillo; Paolo Angeli
Journal:  Hepatology       Date:  2016-02-03       Impact factor: 17.425
  9 in total
  1 in total

Review 1.  Overview of Complications in Cirrhosis.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.